KIMS Hospitals Reports FY26 Revenue of ₹3,904 Cr, Consolidated PAT ₹242 Cr

Krishna Institute of Medical Sciences (KIMS Hospitals) announced its audited financial results for the fiscal year ended March 31, 2026. The company reported consolidated revenue from operations of ₹3,904.60 crore and a consolidated profit after tax (PAT) of ₹242.00 crore.

Key Financials and Appointments

Standalone operations, however, recorded a higher net profit of ₹260.70 crore for the fiscal year, alongside revenue of ₹1,701.50 crore. The company's auditor issued an unmodified opinion on these results. KIMS has appointed Sagar & Associates as its Cost Auditors for FY2026-27. The company also strengthened its senior management with new appointments, including a Chief Finance Officer, Company Secretary & Compliance Officer, and Chief Risk Officer. Additionally, Mr. Adwik Bollineni was re-designated from Non-Executive Director to Executive Director.

Financial Health and Governance

The higher standalone profit indicates strong operational efficiency within the core KIMS entity, complementing the broader group's consolidated performance. These key appointments signal KIMS Hospitals' focus on robust corporate governance and financial oversight.

Growth Through Acquisitions

KIMS Hospitals has pursued an expansion strategy involving both organic growth and strategic acquisitions. Notable acquisitions include Sunshine Hospitals in Hyderabad for ₹360 crore (August 2022) and Spire Hospitals in Bangalore for ₹433 crore (June 2021), which expanded its geographical reach.

Impact on Stakeholders

Shareholders now have clearer insight into the company's financial health and FY2026 growth trajectory. New senior management are expected to drive strategic initiatives and enhance operational efficiency. The cost auditor appointment reinforces compliance and oversight of cost management. Mr. Adwik Bollineni's re-designation to Executive Director suggests a potentially larger role in daily operations.

Risk Assessment

(No specific risks were detailed beyond the auditor's unmodified opinion, which suggests no immediate red flags.)

Competitive Landscape

KIMS Hospitals competes with established players such as Apollo Hospitals, Fortis Healthcare, and Max Healthcare Institute. While KIMS' FY26 consolidated revenue of ₹3,904.60 crore is smaller than larger peers like Apollo (FY24 revenue often over ₹15,000 crore) and Fortis (FY24 revenue often over ₹6,500 crore), its standalone profit surpassing consolidated figures highlights strong core operational performance.

Future Outlook and Key Trackables

• Management guidance for FY2027.
• Performance and integration of recent acquisitions and new facilities.
• Contribution of new senior management to strategic execution.
• Analysis of cost audit reports for efficiency gains.
• Further expansion plans or strategic partnerships.